Corporate ActionJun 15, 2026, 11:52 PM
Alvotech prices $152M public offering & private placement
AI Summary
Alvotech announced the pricing of its underwritten public offering of 22,666,667 ordinary shares at $3.75 per share, expecting gross proceeds of approximately $85 million. Concurrently, the company entered into subscription agreements for a private placement of 17,826,666 ordinary shares at the same price, anticipating gross proceeds of about $67 million. The combined offerings are expected to generate approximately $152 million, or up to $165 million if underwriters fully exercise their option. Proceeds will fund biosimilar asset development, working capital, and general corporate purposes.
Key Highlights
- Alvotech priced public offering of 22,666,667 shares at $3.75 per share.
- Public offering expected to generate gross proceeds of approximately $85 million.
- Underwriters have a 30-day option to purchase up to 3,400,000 additional shares.
- Concurrent private placement of 17,826,666 shares at $3.75 per share.
- Private placement expected to generate gross proceeds of approximately $67 million.
- Total gross proceeds from both offerings expected to be approximately $152 million.
- Total proceeds could reach approximately $165 million if underwriters' option is fully exercised.
- Proceeds will fund biosimilar development, working capital, and general corporate purposes.
Price Impact
More from ALVO